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INTRODUCTION 
 
 Abnormal uterine bleeding (AUB) is a common complaint in 
“gynaecological practice.  It represents a major proportion of 
outpatient attendance.  The most probable cause of abnormal 
uterine bleeding depends on the patient’s reproductive age and the 
likelihood of serious endometrial pathology like malignancy 
increases with age.  The diagnosis of AUB is by exclusion. 
 
 Before hysteroscopy was available, curettage was the primary 
method of evaluating abnormal uterine bleeding.  Brooks and 
Serden have revealed that approximately half of pedunculated 
abnormalities such as endometrial polyps were missed by curettage.  
It renders endometrial sampling blind and incomplete, so the 
diagnostic accuracy of curettage is less than that of hysteroscopy. 
 
 For Focal lesions,  D & C is less accurate and less reliable 
However, it gives histopathological report, which is of immense 
value in the treatment of AUB.  According to Valle, hysteroscopy 
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is not a substitute for tissue diagnosis.  According to Loffer, a 
tissue diagnosis is essential.  Though, transvaginal sonography is 
considered as an initial investigation in patients with AUB, the 
prediction of endometrial pathology based on ultrasound scan in 
premenopausal women is not reliable because of great overlap 
between normal range and those with endometrial pathology.  So, 
hysteroscopy combined with histological examination is the new 
“Gold Standard” for evaluating a case with AUB (Widrich et al , 
Bakour) 
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AIM OF THE STUDY 
 
The objective of the present study is to evaluate the 
usefulness of Hysteroscopy as a screening method in patients 
with AUB in relation to the histopathology results of the 
endometrial biopsy and results of transvaginal sonography. 
1. To evaluate the usefulness of hysteroscopy as a 
screening method in patients with Abnormal uterine 
bleeding.   
2. To compare the efficacy of hysteroscopy in diagnosing 
of endometrial pathology with transvaginal 
sonography and its correlation with histopathology. 
 
 
 
 
 9
REVIEW OF LITERATURE 
HISTORY OF THE TYPES OF THE ENDOMETRIUM IN DUB 
 * As far as 1860, Scansoni stated that the common female 
disease was chronic metritis and that the bleeding was due to 
abnormal brittleness of the arteries. 
 * Remiche (1897), Slocum (1908) and Findley (1905) 
attached importance to the uterine arteriosclerosis as a cause of 
bleeding. 
 *  The term “Apoplexy uterus” is said to have been used by 
Guveilbein as early as 1882. 
 * Brenecke described the so called ‘endometritis oophoritis’ 
which is know as hyperplasia of the endometrium. Then the 
hormonal function of the ovary was not even known. 
 * Pankor (1909) emphasized the term ‘Metropathia 
haemorrhagica’ as there was increased elastic tissue in the blood 
vessel. 
 *   1910 Thailbater denoted the defective contractility of 
mesometrium to embrace connective tissue as well as the 
musculature of the uterus. 
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 *     Later on in 1915, Schroeder evolved a working concept 
of the mechanism involved in Metropathia haemorrhogica, and 
William P also contributed to this study in hysterectomised 
specimens of AUB. 
Endometrial Hyperplasia. 
 * French surgeons Robert (1846), Robin (1848) and Nelton 
(1853), made the first clinical observation of hyperplasia. 
 * Recamier (1850) the inventor of curette, advised curettage 
as a method of treatment and met with strong opposition by Aron 
(1958) and Becaucert (1859)  
 * Olshavsen (1875) described the histology and its 
association with uterine bleeding.  He called it “endometritis 
fungosis” and “chronic hyperplasia”. 
 * Cullen (1900) described in English and coined the term 
“hyperplastic endometrium.” 
 * Robert Schroeder (1915 & 1919) by his epoch making 
work ruled out the older inflammatory theory and correlated 
endometrial hyperplasia with persis. 
 11
 * Robert Meyer (1920) described the ovarian changes and 
drew attention to graffian follicle maturation and their 
disintegration by atresia. 
 * Anatomic studies of E Novak, Seitre, Baher, Reuge, Novak, 
Adler, Martzold, Backmarard, Wilfred shaw were published in 
1920. 
 * Hanghaver (1930) attempted to reproduce hyperplasia by 
injecting anterior pituitary extracts to guinea pigs. 
 * Fluhman (1931) suggested that hyperplasia is due to 
unopposed action of estrogen. 
 * Zucherman and Movie Jeffcoate, Dayne, Taylor Novak 
(1936) said that hyperplasia is due to excessive estrogen. 
 *  Clessens and Cowell found 19% of adolescent girls with 
menorrhagia having a haemostatic defect while Smith et al found 
the incidence to be 33%. 
 *  Falcone et al found only 3.3% of patients admitted for 
menorrhagia over a 10 year period. 
 *   Studies by Ash et al, suggested that menstrual cycle 
irregularity and hypertension were independently significant risk 
factors for detecting abnormal endometrial riskfactors. 
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* Lettererrand Masshoff, 1941 described the glandular 
epithelium of endometrium of cystoglandular hyperplasia. 
* Gruner 1942 described about the luteinisation of follicular 
epithelium that may be reflected in the endometrium as patchy 
secretory changes. 
* Schmidt 1965, Matihesan 1967 studied about estrogen and its 
stimulation of fibrinolytic activity of endometrium 
* Kurman et al 1985 have studied the progression of 
endometrial hyperplasia to carcinoma 
* Sharman and Brown 1979 showed that Grade I and Grade II 
endometrial hyperplasia have 22% and grade III has 57%  chance 
of development of carcinoma endometrium. 
ATYPICAL HYPERPLASIA 
 Cullen as early as 1900 described atypical endometrium 
existing with adenocarcinoma. He suggested that it may be the 
earliest phase of malignancy, not pathognomonic but a sign of 
cancer.  Diagnostic criteria was laid down by Schroeder (1925), 
Taylor (1932), Schroeder (1929), Novak and Yin  (1934) indicated 
that there is some relationship between hyperplasia and corporal 
cancer. Gueberg (1947) believed that there is a constant 
 13
relationship between adenomatous hyperplasia, benign and 
malignant adenoma and estrogen stimulation.  Rutletge and Novak 
(1948) showed similarity between atypical hyperplasia and 
endometrial carcinoma.  Hertig Sommen and Bengloff (1949) in 
their extensive study drew attention to focal and generalized 
adenomatous hyperplasia and development of cancer.  Their studies 
bore no time relation to the development of cancer and 
adenomatous hyperplasia may regress, though in some it was found 
to be the precursor of endometrial cancer.  Sperts’ (1952) excellent 
paper on premalignant phase of endometrial cancer is noteworthy.  
Gusberg (1954), John A wall and Waner’s (1957) paper are for 
adenomatous hyperplasia and precancerous condition.  Compell 
Bastere (1966) and George sipper (1966) laid down criteria for 
diagnosing atypical hyperplasia and its importance in treatment. 
Proliferative Endometrium 
 Anovulatory cycles are common in adolescence and before 
the menopause.  Though the mechanism is not known, the 
menstrual bleeding associated with the shedding of proliferative 
endometrium in the second half of the cycle should always be 
regarded as abnormal. 
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HISTORY OF HYSTEROSCOPY 
 * Visual examination of the uterine cavity is an old 
technique. Pantaleoni, in 1865, was the first to examine the uterus 
using a small tube inserted through the external OS of the cervix 
with a kerosene lamp or a candle for a light source (Lindemenn 
1973) 
 * This first examination was performed as a 60 year old 
woman with intractable post-menopausal bleeding and it was 
reported that polyp like growths were found. 
 * Many technical advances in the optical systems were 
developed in Europe at the turn of the century (Fragenhein 1987), 
but only in the last 25 years have fibre-optic light sources and the 
Hopkins lens system made hysteroscopy a practical diagnostic out-
patient procedure. 
 Endoscopic procedure in general attained a wider acceptance 
after the introduction in 1952, also in France, of the “Cold Light” 
concept by Fourestier, Gladu and Vulmiere.  This innovation 
permitted great improvements to be made in the equipment.  In the 
same year, Hopkins and Kapany in England introduced fiberoptics 
to the field of endoscopy. 
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 Hysteroscopy was the earliest form of endoscopy.  The 
introduction of effective uterine distress media – high molecular 
weight dextran (Edstrom and Fernstrom, 1970), CO2 (Lindemann 
1970), 5% dextran (Norment and Sykes, 1972) – made 
hysteroscopy, a practical procedure.   
 The microcolpohysteroscope was introduced by Hamou in 
1980.  The American Association of Gynaecological laprascopists 
(AAGL) was found in 1972. This organization has played a major 
role in the dissemination of endoscopic knowledge in North 
America and in many parts of rest of the world. 
 Author (PT) was preveledged to be the scientific chairman 
for the first practical course in hysteroscopy offered by the AAGL 
at the virgin masou clinic in Seattle, Washington in 1982. 
 HPE OF Endometrium 
 DUB should be evaluated promptly which is primarily 
associated with ovarian dysfunction and or anovulation. 
 1.  By doing HPE of the endometrium 
 2.  By studying the endometrial thickness using  
  transvaginal probe 
 3.  Direct visualization of the endometrial cavity using  
  hysteroscopy 
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 In evaluation of AUB, the following principles should be 
borne is mind. 
 It is essential to exclude organic diseases if necessary by 
repeated examination and special investigation. 
 The morphology of endometrium lightly responds to ovarian 
steroid hormones and changes in the hormones are specifically and 
promptly reflected in the endometrium.  Endometrial biopsy is the 
convenient procedure traditionally used is gynaecology.  
Interpretation of endometrial biopsy specimens provides  
reasonable accurate measurement to steroid stimuli.  The relative 
ease with which endometrium may be biopsied has permitted the 
histological diagnosis of the disease of the uterus and afforded 
opportunity to evaluate the various physiological and 
pathophysiological events which have an impact on menstrual 
function. 
 
 
 
 
 
 17
HISTOPATHOLOGY OF ENDOMETRIUM IN DUB 
 
 Classification of possible endocrine abnormality associated 
endometrial histology and typical bleeding pattern in DUB. 
 
Type Endocrine Abnormality and 
Endometrial Histology 
Typical bleeding 
pattern 
Normal 
ovulatory 
* Short cycle – short proliferative 
   Phase – normal endometrium 
* Long cycle – long proliferative 
phase – normal endometrium 
Polymenorrhea 
Menorrhagia 
Oligomenorrhea 
menorrhagia 
Corpus luteum 
abnormality 
* Insufficiency – short luteal phase 
– irregular or deficient secretory 
endometrium 
* Persistent (Halbans disease) 
irregular endometrial shedding 
Premenstrual 
spotting 
Menorrhagia 
 
Anovulatory * Insufficient follicles – short cycle 
inadequate proliferative or atrophic 
endometrium 
* Persistent follicle or PCOS – 
prolonged cycle proliferative or 
hyperplastic endometrium 
Polymenorrhea 
Metrorrhagia 
 
Oligomenorrhea 
Metropathia 
haemorrhagica 
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Endometrial Pattern in DUB 
I Ovulatory           -  Irregular shedding 
         Irregular ripening 
II Anovulatory - Proliferative 
     Hyperplastic 
   - Simple cystoglandular hyperplasia 
   - Complex adenomatous hyperplasia  
without atypia 
   - Atypical (Adenomatous with atypia) 
III Atrophic 
 Abnormal functional bleeding may be associated with any 
type of endometrium even normal secretory endometrium.  This 
may be due to variation in vasculature of some local defect within 
the uterus. 
 Ovulatory endometrium indicates persistence of secretory 
changes suggesting a persistence or over activity of corpus luteal 
function. 
 To assess this pattern of bleeding, biopsy should be done in 
immediate post-menstrual period. 
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Irregular shedding 
 On histological examination, there is predominance of 
proliferative endometrium. 
Irregular Ripening 
 First described by Traut and Kinder at al in 1935.  On 
histological examination, there is mixture of both proliferative and 
secretory endometrium 
Anovulatory endometrium, proliferative phase 
 The proliferated glandular cells are columnar and the 
elongated nucleus has coarse chromatin which fills most of the cell.  
The nuclei give a pseudostratified appearance.  The cystoplasm is 
scanty. Cilia may be present.  The stroma is heavily infiltrated with 
leucocytes and red cells and the vessels are thin walled and straight. 
Endometrial Hyperplasia 
 In 1988, the nomenclature committee of the international 
society of Gynaecologic pathologists adopt the following 
modification of terms for endometrial hyperplasia. 
1. Simple hyperplasia (Cystoglandular hyperplasia) 
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2. Complex hyperplasia (Adenomatous hyperplasia without 
atypia) 
3. Atypical hyperplasia (Adenomatous hyperplasia with atypia) 
Endometrial Hyperplasia represents a spectrum of morphologic 
and biologic alterations of the endometrial glands and stroma, 
ranging from an exaggerated physiologic state to carcinoma in situ. 
 Clinically significant hyperplasias usually evolve within a 
back ground of proliferative endometrium as a result of protracted 
estrogen stimulation in the absence of progestin influence. 
 The most recent classifications scheme endorsed by the 
International Society of gynaecological pathologists is based on 
architectural and cytologic features as well as long term studies that 
reflect the natural history of the lesions. 
Classification of Endometrial hyperplasias 
Type of hyperplasia   Progression to carcinoma 
Simple (cystic without atyptia)   1% 
Complex (adenomatous without atypia)  3% 
Atypical 
Simple (cystic with atyptia)    8% 
Complex (adenomatous with atypia)  29% 
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Simple hyperplasia (Cystoglandular Hyperplasia) 
 It is seen in perimenopausal women that the glands may be of 
varying sized and some are cystic.  They are lined by multi-layered 
cuboidal or tall columnar epithelium.  The stroma is increased and 
densely cellular. 
Complex Hyperplasia (Adenomatous Hyperplasia without 
Atypia) 
 Microscopically there is an increase in the number and size of 
the endometrial glands which are crowded together with scanty 
stroma in between.  The glands are lined by hyperplasia stratified 
epithelium with finger like out pouchings into the stroma as well as 
papillary budding of the epithelium into the glandular lumen. 
Atypical Hyperplasia (Adenomatous hyperplasia with Atypia) 
 The lining epithelium of the glands are large, irregularly 
heaped up, columnar cells with large irregular nuclei and loss of 
polarity.  
 The cytoplasm has dense, abundant eosinophilic staining. 
 There is also back to back glandular crowding with reduction  
and papillary infolding of the glandular epithelium. 
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Atrophic endometrium 
 The glands are found dilated and they are lined by flat 
cuboidal epithelium.  The stroma is edematous and sparsely 
cellular. 
 Apart from the fact that hyper estrogenic level is responsible 
for abnormal bleeding, psychological factors also play a role in 
patients perceiving uterine bleeding as excessive. 
 The studies with special stains expands the parameters of one 
observations of ovulatory and anovulatory endometrium. 
 The positive staining for glycogen in secretory endometrium 
indicates ovulatory endometrium and the positive staining for 
collagen in hyperplastic endometrium indicates anovulatory 
endometrium. 
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ROLE OF TVS IN  AUB 
 Probably the commonest complaint in a woman is irregular 
bleeding disorders, menorrhagia etc.  This forms the commonest 
indication for the Ultrasound examination before any invasive 
method. 
 Ultrasound scan, particularly the transvaginal route is used to 
assess endometrial thickness, endometrial and myometrial 
consistency and abnormalities of endometrial morphology like 
submucosal fibroid or polyp etc. 
 It has been recommended that in patients with menorrhagia, 
the uterine cavity should initially be investigated using transvaginal 
sonography.  Transvaginal sonography is preferable to pelvic ultra 
sonography because of better quality of its image.  This is achieved 
because of its higher frequency which allows greater image 
resolutions at the expense of decreased depth of penetrations.  So 
transvaginal sonography can be considered a first line of 
investigation for women with AUB. 
 Ultrasonography especially transvaginal is an inexperience, 
non invasive, convenient way to indirectly visualize the 
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endometrial cavity. It is a safer, painless, convenient method of 
diagnosing those with pathology.   
 Any women who presents with AUB cannot be labeled as 
AUB usually as clinical examination alone can only detect 9 % 
percent of anatomic findings as compard to 31 % by ultrasound. 
 USG is helpful in excluding many patients with anatomic 
findings not detected by physical examination, eg. Intramural, 
subserous, submucous fibroids, endometrial or fibroid polyp, 
PCOS,congenital anomalies of uterus and endometrial carcinoma.  
It also helps in the evaluation of endometrium. 
 Thus USG has an increasingly important role in evaluating 
certain disorders of the endometrium. It also guides in the need for 
correction of anovulation depending on the age group.  Thus, USG 
examinations provides  a method of evaluating symptomatic 
patients and for identifying any remaining endometrium that could 
later on become symptomatic. 
• Atrophic endometrium – very thin bright interface in the 
centre of the uterus. 
• Endometrial Hyperplasia – Echogenic thick endometrium not 
correlating to the day of menstrual cycle. 
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An endometrial thickness of more than 18 mm at perimenopause 
carries a 20% risk of endometrial malignancy.  If these patients are 
on HRT, the cut off thickness is 10 mm. 
• Endometrial polyps – These polyps can be microscopic or 
macroscopic.  A polyp of 5 mm can be visualized by TVS.  If there 
is fluid in the endometrial canal these polyps are better delineated. 
Intra-luminal polyps can be diagnosed to almost 100% accuracy by 
high resolution. 
Misplaced IUCDS 
 TVS can detect myometrial burying partial perforation and 
cervical displacement of any type of IUCD.  This will help in 
proper planning of hysteroscope or laparoscopic removal of the 
misplaced IUCD. 
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PLACE OF DIAGNOSTIC HYSTEROSCOPY IN AUB 
 The diagnosis of AUB is by exclusion.  The specific 
diagnostic approach depends on whether the patient is 
premenopausal, or postmenopausal.  In perimenopausal patients, 
endometrial biopsy and other methods of detecting endometrial 
hyperplasia or carcinoma must be considered early in the 
investigation.  Thus in this age group, endometrial biopsy or 
transvaginal ultrasonography is included in the initial investigation 
followed by hysteroscopy. 
 Hysteroscopy and USG are now being increasingly used not 
only for detecting functional disorders of endometrium but also for 
excluding various unsuspected organic diseases of the endometrium 
like cancer and Tuberculosis. 
 The way to perform a thorough hysteroscopic inspection of 
the uterus has been well described.  It is important to perform the 
procedure under direct vision without routine blind dilatation, 
which can lead to pain and suboptimal visualization, secondary to 
bleeding from genital tract trauma.  The operator should obtain a 
panoramic view of the whole cavity and orientate in relation to 
uterine landmarks – cornua, tubal ostia, fundus.  In most cases this 
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is a simple procedure although a small but significant number 
become problematic. Good technique and an understanding of the 
limitation of hyperoscopic diagnosis are important. 
 Hysteroscopy is the standard procedure for detecting 
intrauterine structural pathology (Widrich). Macroscopic inspection 
of the uterine cavity cannot, however, make histological diagnosis 
directly.  Within the clinical context, therefore, hysteroscopic 
diagnosis incorporating morphological features would be better 
classified as normal, abnormal (thickened), abnormal (suspicion) or 
abnormal (cancerous), consistent with the capability of the 
technology. (Bakour). 
 Studies comparing hysteroscopy with traditional D and C 
have suggested that the former is superior.  However the existing 
data supporting the use of hysteroscopy is generally related to 
detection of benign disease and structural pathology.  Hysteroscopy 
appears to be better than ultra-sonography in detecting intra-uterine 
structural pathology (clerk) although results with saline infusion 
sonography are similar (Soares). 
 Subgroup analysis suggests that diagnostic accuracy of both 
outpatient and inpatient hysteroscopy was high for endometrial 
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cancer, although there was a trend towards higher accuracy in the 
outpatient setting (Clark).  The video imaging and small diameter 
endoscopes (<5mm diameter) also improved accuracy. 
 The introduction of outpatient of diagnostic procedure has 
benefited both patients and the health service in terms of 
convenience, reduced morbidity and costs.  Following this 
diagnostic process and inpatient surgical intervention such as D&C, 
polypectomy, endoscopic procedure or hysterectomy is often 
recommended.  Intra-uterine structural pathology (eg.endometrial 
polyps and sub-mucous fibroids) is found in around 25 percent of 
women with abnormal uterine bleeding and accounts for much of 
this surgical activity. 
 The same advances in endoscopic technology that helped 
outpatient hysteroscopic diagnosis happen now offer the possibility 
of outpatient hysteroscopic treatment for such conditions like 
polyps, intracavity fibroids, septas and adhesions.  However 
inpatient endoscopic treatment of these conditions has been 
recommended (RCOG press). 
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MATERIALS AND METHODS 
PATIENT POPULATION 
 Our study includes 50 women age varying between 28 to 55 
years who were admitted.  We included only the patients with 
technical success in transvaginal sonography and Hysteroscopy in 
this study.  Finally 50 patients with pathological confirmation were 
included in this study.  All 50 patients were first evaluated with 
transvaginal sonography followed by Hysteroscopy and traditional 
curettage with cervical biopsy performed after 2 days following 
transvaginal sonography.  The pathological findings are then 
correlated with ultra-sound finding and diagnosis by hysteroscopy. 
Criteria for Selection 
1. Patients who had AUB for more than 6 months were 
selected 
2. Patients in Reproductive and perimenopausal age were 
selected 
3. Both Nulliparous and parous women were included 
4. Patients in pubertal age group were excluded 
5. Both treated and untreated patients were taken 
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6. Patients with any temporary method for the past 6 months 
were excluded 
7. Patients who underwent abortion were excluded 
8. Patients with any other medical or surgical illness were 
excluded 
9. Lactating mothers were excluded 
 Ethical committee approval and informed consent from the 
patients taken.  Patients are also investigated if they have Intra-
uterine device or not, oral contraceptive use, regular drug or 
hormonal preparation usage.  Former gynaecological operations 
and applications recorded. Patients detected to be pregnant are not 
included in the study. 
 Transvaginal ultra-sonography is applied with 7 MHZ 
vaginal probe to all patients who were selected for research.  
Cervix, cervical canal, myometrium and ovaries were examined is 
saggital and coronal section. After inspection of morphological 
pattern of endometrium, endometrial thickness of external borders 
measured and recorded in thickest place in longitudinal place. 
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 DIAGNOSTIC HYSTEROSCOPY 
INSTRUMENTATION : 
TELESCOPES 
The most important piece of equipment for hysteroscopy is the 
lens or telescope.  The optics as well as the fiberoptic illumination 
bundles are packaged together in this single instrument.  Most rigid 
telescopes range in diameter from 2 to 4 mm (o.d.).  The best light 
shower and optical resolution are likely to be found in 4 mm (o.d.) 
instruments. However, for office hysteroscopy, as well as operative 
procedures, a 3 mm telescope can Produce an acceptable video 
image particularly when magnified by means of a zoom video 
camera.   
The smaller telescope permits the operator to employ a 
smaller sheath.  Although flexible telescopes are now finding their 
way onto the market, they suffer from inferior resolution compared 
to that of the rigid equipment.  The most convenient length for the 
hysteroscopic telescope is 35 cm.  Shorter instruments offer no 
advantage and some distinct disadvantages when coupled to 
operative sheaths.  The telescope consists of three major parts: 
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•  The magnifying eyepiece. 
• The transmitting lens system. 
• The objective lens 
           The most commonly used terminal objective lenses provide 
a straight on view (00) or offset view (300).  Selection of the lens is 
a matter of personal preference but for the best panoramic operative 
view the 00 lens is recommended, particularly when using laser 
fibers or flexible or semirigid operating accessories.  Rigid lenses 
are fragile and must be handling, steam autoclaving, improper 
liquid disinfection and inadequate cleaning will shorten the life of 
the telescope and require expensive repairs as well as system down 
time.  A properly cared for lens will last a lifetime and provide 
excellent service over and over again. Located just below the 
eyepiece is the fiberoptic coupling connection.  At this location the 
fiberoptic cable joins, the telescope.  Each lens manufacturer has a 
unique coupling.  Several companies supply attachments that 
permit a variety of cables to join their particular instrument.  The 
latter is an advantage since any light generator and light cable can 
be used with a given telescope. 
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FIBEROPTIC LIGHT CABLE 
           Fiberoptic cables transmit intense cold light to the telescope 
and form a conduit, which connects the high intensity (heat 
producing) generator to the telescope.  The cable is filled with 
many incoherent drawn-out glass fibers capable of conducting light 
from the generator to the terminus of the cable.  Obviously these 
cables are fragile and can be easily damaged if not handled 
carefully.  Inspection of the end of the cable will readily determine 
whether fibers or groups of fibers have been broken.  These are 
indicated  by dark spots in an otherwise intense light shower.   
  Inspection of the periphery of the cable in a darkened room 
can also reveal fiber disruption.  This appears as light transmission 
through the sides of the cable.  Poor light at the end of the telescope 
is almost always due to a damaged cable.  The only alternative to 
substandard light is to replace the cable.  Cable should be 
disinfected by soaking in cidex (glutaraldehyde) for 15-20 minutes, 
followed by thorough washing in sterile water.  At the end of the 
case, the fiber should be washed again, resoaked and cleansed again 
with water.  The cable should then be stored dry in a protective 
container. Most hospitals and surgicenters have replaced liquid 
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disinfect on with gas sterilization.  The only drawback to the latter 
is the long period required for aeration. 
Light Generator 
          Several varieties of light generators are available on the 
market.  These range from simple and inexpensive tungsten light 
generators (US $500-700) to costly xenon generators US$2000-
5000).  For office use a simple apparatus will suffice, however, 
hysteroscopy performed in the operating room under video control 
demands intense light.  Xenon (300W) generators produce white 
light which is most favourable when coupled with endoscopic 
television cameras (Baggish, 1997).  Characteristically the simpler 
tungsten light generators produce an orange tinted light  which 
creates a rather poor color on the video monitor.  Between these 
two types of generator are the 250 W metal halide generators.  
These produce intense light, which is adequate for video images, 
but characteristically give off a bluish tinge.  The light bulbs in all 
these generators produce a lot of heat, so a fan is built into the 
cabinet to dissipate the heat and prolong bulb life.    . 
           Light generators and fiberoptic cables can be used 
interchangeably for hysteroscopy or laparoscopy.  Obviously the 
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more powerful generators are required for laparoscopy.  All 
generators should be appropriately grounded and should be 
periodically inspected (and indexed)  biomedical engineering for 
low frequency electrical leakage. 
Hysteroscopic Sheaths 
          Two general categories of sheaths are used for hysteroscopic 
procedures: diagnostic and operating.  A sheath is required for 
panoramic hysteroscopy in order to serve as a conduit through 
which to instill the distending medium into the uterine cavity.  The 
diagnostic sheath fulfils this singular requirement and measures 
approximately 4-5m in outer diameter (when coupled to a 3-4 mm 
telescope).  The sheath is essentially a hollow stainless steel tube 
equipped with a proximal port through which the distending 
medium is injected. The telescope must couple tightly to the sheath 
with sufficient seal to prevent medium leakage at the 
telescope/sheath, interface.  The objective lens of the telescope 
should fit precisely, flush with the end of the sheath to produce an 
unobstructed view.  Therefore each given manufacturer’s lens must 
be matched correspondingly to the same manufacturer’s sheath.  
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The coupling mechanisms differ for different hysteroscopes, 
preventing the interchange of lenses and sheaths.   
          A 5 mm sheath ordinarily will allow passage through 
nulliparous cervices without resorting to dilatation.  A 4 mm sheath 
equipped with a 3 mm telescope can negotiate the endocervical 
canal most easily than the  5 mm sheath., and is ideal in the office 
setting.  They are therefore ideally suited to office hysteroscopy.  
Hysteroscopic sheaths are sturdy  and stand up to routine handling.  
They may be steam autoclaved.  Obviously they should be 
thoroughly flushed and cleansed after usage and stored away clean.  
The stopcock mechanism should be disassembled, cleaned, 
lubricated and reassembled after each usage.  The stopcock should 
be turned to the open position when stored, from time to time the 
sheath as well as the shaft of the telescope should be polished with 
a high quality. 
ABNORMAL UTERINE BLEEDING 
            Abnormal uterine blooding is the most common complaint 
of patients consulting the gynecologist and provides the most 
frequent indication for hysterectomy.  D and C has been the 
diagnostic method of choice for many decades for these cases. 
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However, for diagnosing non-malignant intrauterine pathology 
such as endometrial polyps. and intrauterine leiomyoms which may 
cause uterine blooding disorders, D and C appears to be unreliable 
(Wamsteker, 1977, 1984a; Gimpelson and Rappold.  1988.  Loffer 
1989; Motashaw and Dave. 1990). 
         Direct hysteroscopic inspection with adequate distention and 
visualization discloses almost every intrauterine abnormality with 
high accuracy.  Additionally, it enables exact localization of the 
pathology and determination of its intracavitary extent.  However, 
for the diagnosis of endometritis and adenomyosis, conclusive 
hysteroscopic criteria are still lacking.   
         For histologic examination selective samples of any abnormal 
tissue can be obtained by visually controlled biopsies.  A 
significant percentage of benign intrauterine pathology disclosed by 
hysteroscopic diagnosis in patients with abnormal uterine bleeding 
can be treated with minimally invasive transcervical hysteroscopic 
endosurgery.  
           As the majority of intrauterine disorders resulting in 
abnormal uterine bleeding in the reproductive phase of life, the 
climacteric and the postmenopausal period, are benign types of 
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pathology, D and C can be longer hold its position as the primary 
diagnostic method for patients with abnormal uterine bleeding.  
Today ambulant or outpatient hysteroscopy with visually directed 
biopsies or directed curettage is to be recommended as the 
diagnostic method of choice for these cases. 
         With the more recently developed continuous how (CF) 
technique the surface structure of the endometriun can be observed 
with very low intrauterine pressure, which prevents compression of 
the soft tissue of the mucosa and also reduces the transtubal flow of 
the distention medium.  
          Extensive studies have not indicated any negative effect of 
abdominal spill of the gas or liquid used for distention of the 
uterine cavity in panoramic hysteroscopy in cases of endometrial 
cancer (Wamsteker, 1977, Neis et al ,1994. 
           Review of the literature does not indicate that hysteroscopy 
with abdominal spill of the distention medium should be considered 
more hazardous in cases of endometrial cancer than D and C used 
alone.  Although D and C will seldom fail to disclose endometrial 
cancer and hyperplasia, hysteroscopic investigation additionally 
enables the early detection of small endometrial cancers and 
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determination of the localization, size and extent of the neoplasia 
and /or its precursors.  Notwithstanding the above-mentioned 
considerations it seems to be sensible to recommend reducing 
transabdominal spill of distention medium as  much as possible in 
these cases.  This can be achieved reducing  the intrauterine 
working pressure during hysteroscopy in cases suspected of 
endometrical cancer.   
Specific indications for hysteroscopic diagnosis in patients 
with abnormal uterine bleeding are: 
• Hypermenorrhea or menorrhagia. 
• Metrorrhagia 
• Intermenstrual bleeding 
• Postmenopausal bleeding 
• Intrauterine or endometrial abnormality on TVS or HSG. 
          In cases of cervical dysplasia or malignancy accurate in vivo 
diagnosis on a cellular level can be performed with contact 
microcolpohysteroscope (Hamou, 1981). However, experience with 
determining cytologic pathology is a prerequisite for this technique. 
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 Patients admitted, evaluated to rule out systemic illness and 
then subjected to hysteroscopy after informed consent.  Under strict 
aseptic precautions, under Total intra-venous Anaesthesia, patient 
put in Lithotomy position KARL STORZ hysteroscope introduced.  
Cervical canal examined followed by a panoramic inspection of 
whole endometrial cavity in relation to uterine landmarks – cornea, 
tubal ostia and fundus. 
 Atophic endometrium is thought, when the cavity is thin, 
pale, smooth surface and sometimes tiny petechial bleeding seen. 
Endometrial tissue covering smooth surface – pedunculated 
or non-pedunculated structure are evaluated as polyp. Lesions not 
concerned with endometrium, shiny as pearl, sessile appearing and 
vascularisation are submucous myomas.  
 If endometrial surface is smooth or thickened in polypoidal 
appearance, when pressed wit hysteroscope, endometrial groove is 
seen it is called Hyperplasia. When this thickening is together with 
high grade irregularity, it is called Atypical Hyperplasia.  If 
necrotic areas, glandular and vascular disorganization is present in 
addition to this appearance endometrial carcinoma is thought of. 
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 Dark red coloured relatively with smooth surface or lesions 
seen independent from necrotic endometrium are evaluated as 
retention of placental tissue.  All other finding except from above 
are accepted as normal endometrium. 
 Normal endometrium and atrophic endometrium are accepted 
as normal hysteroscopic findings.  Dilatation and curettage is 
performed to all patients.  Obtained material is preserved in 
formulin and sent to Histopathology laboratory for confirmation of 
diagnosis.  Endometrial hyperplasia, polyp, myoma and placental 
polyps are accepted as pathological results.  
 When no material is obtained and histological finding as 
secretory endometrium, proliferative endometrium, normal and 
Atrophic endometrium are evaluated. Chi square and Fischer 
extract tests are used to compare the rates P value < 0.05 is 
accepted as significant. 
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ANALYSIS OF THE STUDY 
Table – 1 
Age Distribution 
Age in Years No.of patients Percentage 
Reproductive age group 
20  -  30 yrs 
 30 – 40 yrs 
 
10 
25 
 
20 % 
50 % 
Perimenopausal age group 
40 – 50 yrs 
 
15 
 
30% 
 
Age Distribution : 
 Analysis of women age wise revealed that 10 out of 50 
patients belonged to 20-30 years. 
 Among 50 patients, 35 of them belonged to 
reproductive age group and 15 of them to perimenopausal age 
group. 
            Most of the people in the study belonged to 30-40 yrs of 
age. 
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Table – 2 
Socio economic Status 
 I II III IV V 
Reproductive 
age group 
0 0 0 
13 
(26%) 
22 
(44%) 
Perimenopausal 
age group 
0 0 
2 
(4%) 
5 
(10%) 
8 
(16%) 
 
 Among reproductive age group, 44% of the patients belong to 
class V, socio economic status 26% belong to class IV socio 
economic status.  Among perimenopausal age group, 16% patients 
belong to class V socio economic status, 10% belong to class IV 
and 4% belong to class III socio economic status. 
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Table – 3 
Previous Treatment 
Treated Not treated 
 
No. % No. % 
Reproductive 
age group 
7 14 28 56 
Perimenopausal 
age group 
8 16 7 14 
 
 14% of patients in reproductive age group had treatment 
previously while 16% of patients in perimenopausal age group had 
been treated previously for AUB. 
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Table - 4 
Among the treated patients, type of treatment given 
 
Placebo Hormones Non hormone D&C  
No % No % No % No % 
Reproductive 
age group 
20  -  30 yrs 
 30 – 40 yrs 
 
 
2 
2 
 
 
4 
4 
 
 
0 
2 
 
 
0 
4 
 
 
0 
0 
 
 
0 
0 
 
 
0 
1 
 
 
0 
2 
Perimenopausal 
age group 
40 – 50 yrs 
 
 
5 
 
 
10 
 
 
1 
 
 
2 
 
 
2 
 
 
4 
 
 
0 
 
 
0 
  
Most of the patients in reproductive age group were given 
hormonal treatment when compared to patients in perimenopausal 
age group. Placebo   was given to many patients.  Non hormonal 
treatment like antifibrinolytics were given to 4% of perimenopausal 
age group.  In 2 % of the patients in reproductive age group, 
dilatation and curettage was done. 
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Table – 5 
Pattern of Cycle 
Regular Irregular  
No % No. % 
Reproductive  
age group 
27 54 8 16 
Perimenopausal  
age group 
4 8 11 22 
 
 54% of patients in reproductive age group had regular 
menstrual cycle while 16% patients had irregular cycle. 
 Among perimenopausal age group, 22% of patients had 
irregular cycles and 8% of the patients had regular cycle. 
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Table – 6 
Menstural flow patterns 
Excess flow Prolonged flow 
Excess and 
prolonged 
 
No % No % No % 
Reproductive  
age group 
18 36 6 12 11 22 
Perimenopausal age 
group 
4 8 4 8 7 14 
 
 36% of patients in reproductive age group had menorrhagia, 
12% had hypermenorrhea while 14% of patients in perimenopausal 
age group suffered from menorrhagia. 
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Table – 7 
Parity 
Nullipara Unipara 
Multiparous 
(2-5) 
Multiparous 
(>5) 
 
No % No % No % No % 
Reproductive  
age group 
3 6 9 18 23 46 0 0 
Perimenopausal 
age group 
1 2 5 10 7 14 2 4 
 
In reproductive age group, 6% of patients were nulliparous, 
18% uniparous and 46% were multiparous women. 
In perimenopausal age group, 2% patients were nullipara, 
10% were uniparous and 4% patients multipara. 
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Table – 8 
Contraception and DUB 
Temporary No 
contraception
Permanent 
contraception DC IUCD Others 
 
No % No % No % No. % No % 
Reproductive  
age group 
10 20 15 30 3 6 7 14 0 0 
Perimenopausal 
age group 
3 6 12 24 0 0 0 0 0 0 
 
Patients who have undergone sterlisation had increased 
incidence of AUB. Probable reason may be 
1. The blood supply to the ovary is altered 
2. The axis of ovary is sometimes changed due to 
adhesions. 
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Table – 9 
Pain with AUB 
Patients with pain Patients without pain 
 
No % No % 
Reproductive  
age group 
28 56 7 14 
Perimenopausal 
age group 
5 10 10 20 
 
56% of patients in reproductive age group had ovulatory 
AUB which 20% of patients among perimenopausal age group had 
anovulatory AUB. 
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Table – 10 
Weight of the patient 
Within the ideal weight More than Ideal weight 
 
No % No % 
Reproductive  
age group 
22 44 13 26 
Perimenopausal 
age group 
4 8 11 22 
 
44% of the patients among reproductive age group were 
within ideal weight while most of the perimenopausal patients with 
AUB had more weight. 
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Table – 11 
Blood grouping 
Rh Typing A B O AB 
+ve -ve 
 
No % No % No % No % No % No %
Reproductive  
age group 
2 4 27 54 5 10 1 2 33 66 2 4 
Perimenopausal 
age group 
4 8 7 14 2 4 2 4 14 28 1 2 
 
It was an incidental finding that among the study group, most 
of them belong to the B group. 
No other bleeding disorders were noted among the study 
group.  No other thyroid dysfunction was detected. 
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Table – 12 
TVS Endometrial thickness 
Endometrial Thickness 
1 
mm 
1-3 
mm 
3- 5 
mm 
5 – 8 
mm 
8 – 10 
mm 
> 1 
cm 
 
No % No % No % No % No % No %
Reproductive  
age group 
0 0 15 30 19 38 1 2 0 0 0 0
Perimenopausal 
age group 
0 0 5 10 1 2 5 10 3 6 1 2
 
In the study of the endometrial thickness of the reproduction 
age group, pencil line endometrium was nil, 15 had 1-3 mm, 19 
patients 3-5mm thickness, 1 had 5-8mm thickness, non had > 1 cm 
thickness. 
Among perimenopausal age group, pencilline endometrium 
was nil, 5 had 1-3mm thickness, patient had 3-5mm thickness and 3 
patients had 8-10mm thickness and 1 patient had thickness > 1cm. 
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Table – 13 
HPE Report 
Atropic Proliferative Secretory Adenomatous Atypical AdenoCa Endometritis Cystoglandular hyperplasia 
 
No % No % No % No % No % No % No % No % 
Reproductive 
age group 
0 0 16 32 11 22 1 2 0 0 0 0 1 2 6 12 
Perimenopausal 
age group 
0 0 5 10 6 12 0 0 0 0 0 0 0 0 4 8 
 
In the reproductive age group HPE consisted mostly of proliferative (32%) and secretory (22%) pattern. One 
case of Adenomatous pattern and 1 case of endometritis detected 12 % cases of cystoglandular hyperplasia were 
noted. 
In the perimenopausal age group, 12% of secretory changes, 10% with proliferative changes and 8% of cases 
with cystoglandular hyperplasia were noted. 
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Table – 14 
Biopsy Ectocervix 
Normal cervix 
Inflammmatory 
condition 
Cervicitis Dysplasia 
 
No % No % No % No % 
Reproductive 
age group 
12 24 18 36 5 10 0 0 
Perimenopausal 
age group 
2 4 9 18 3 6 1 2 
 
Among reproductive age group, 12 cases were normal, 18 
cases of ectocervical biopsy revealed inflammatory changes, 5 cases 
– cervicitis. Among perimenopausal age group, 2 cases were with 
the normal ectocervix, 9 cases showed inflammatory changes, 3 
cases were with dysplasia, 1 case with dysplastic change. 
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Table - 15 
Distribution of uterine pathology regarding TVS 
 
Uterine Pathology No.of cases % 
Hyperplasia 9 18 
Polyp 5 10 
Myoma 2 4 
Polyp + Myoma 0 0 
Cancer 0 0 
No pathology 34 68 
 
In both reproductive and perimenopausal age group, according 
to transvaginal sonography, 9 cases showed endometrial hyperplasia, 
5 cases were with endometrial polyp, 2 cases showed submucous 
myoma and the remaining 34 cases were with nil pathology. 
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Table - 16 
Distribution of Uterine pathology regarding hysteroscopy 
Uterine Pathology No.of cases % 
Hyperplasia 15 30 
Polyp 12 24 
Myoma 2 4 
Polyp + Myoma 1 2 
Cancer 0 0 
No pathology 20 40 
 
According to hysteroscopy, 15 cases were diagnosed with 
endometrial hyperplasia, 12 cases showed endometrial polypoidal 
growths, 2 cases were diagnosed as submucosa myoma, 1 case as 
with both endometrial polyp and submucosa myoma and 20 cases 
showed no pathology. 
 
 
 
 58
 
Table – 17 
Distribution of Uterine pathology regarding  D & C 
Uterine Pathology No.of cases % 
Hyperplasia 10 20 
Polyp 5 10 
Myoma 0 0 
Polyp + Myoma 0 0 
Cancer 0 0 
Adenomatous 1 2 
Endometritis 1 2 
No pathology 33 66 
 
According to dilatation and curettage biopsy, 10 cases (20%) 
showed cystoglandular hyperplasia, 5 cases (10%) showed 
polypoidal growth, 1 case (2%) of endometritis and 33 cases (66%) 
were with normal histopathology. 
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Table - 18 
Distribution of Intra uterine pathology according to TVS, D&C 
hysteroscopy 
 
TVS and D&C Hysteroscopy and D&C  
No % No % 
Hyperplasia 9 18 15 30 
Polyp 5 10 12 24 
Myoma 2 4 2 4 
Polyp + Myoma 0 0 1 2 
Cancer 0 0 0 0 
No pathology 34 68 20 40 
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DISCUSSION 
 Abnormal uterine bleeding is a common problem (Couher) and 
is the main indicator for hysteroscopic evaluation.  Hysteroscopy 
and USG are now being increasingly used not only for detecting 
functional disorders of endometrium, but also for excluding various 
unsuspected organic diseases of the endometrium like cancer and 
tuberculosis. 
 In this series 50 patient with AUB were taken for study.  For 
all 50 patients, TVS, hysteroscopy and D&C were done in the 
premenstrual phase and analysis of the study has been done.  The 
study period consisted of 2 years – during the year 2008 – 2009 in 
Government Rajaji Hospital. Majority of the patients belong to 
reproductive age between 30-40%.  Only 30% belong to the age 
group of 20-30 years. 
 All the 50 patients were married, out of which 6 were 
widowed. 
¾ Regarding the parity, in the reproductive age group, most of 
them are multiparus (46%), uniparous 18%, and nulliparaous 
6% . In the perimenopausal age group, multiparous were 18%, 
uniparous 10% and nulliparous accounted for 2%. 
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¾ The flow pattern and cycles varied and were analysed 
according to the individual picture.   
¾ It was found that most of the patients around were sterlised.   
¾ In the reproductive age, 44% were within ideal weight and in 
premenopausal age, there was 22% increased weight. 
¾ Most of them belonged to the B group according to our study. 
¾ In all the patients, endometrial thickness measured by 
Sonogram was compared with HPE. 
¾ Comparing the distribution and diagnosis of intra uterine 
pathology according to transvaginal sonography, D&C and 
hysteroscopy showed that 30% hyperplasia was detected by 
combination of hysteroscopy and D&C whereas TVS and 
D&C could detect only 18% of hyperplasia. 
¾ Combination of hysteroscopy and D&C could detect 24% of 
cases with endometrial polyp while TVS and D&C could 
detect only 10% of cases with endometrial polyp. 
¾ Both combination of transvaginal sonography and D&C could 
detect 4% of cases as with sub mucous myoma but 
combination hysteroscopy and D&C in addition, could detect 
2% of case as with both myoma and polyp. 
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¾ 40% of cases showed no pathology according to diagnostic 
hysteroscopy and D&C whereas TVS and D&C could not 
detect any pathology in 68% of AUB cases. 
¾ Thus combination of diagnostic hysteroscopy and D&C has 
better diagnostic value when compared with transvaginal 
sonography and D&C. 
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SUMMARY 
 
¾ A total of 50 cases of DUB have been selected.  35 from 
reproductive age group and 15 from perimenopausal age 
group. These patients were subjected to TVS, hysteroscopy 
and D&C on two successive days in the premenstrual phase. 
¾ Among the reproductive age group, 20% belong to the age of 
20-30 year and 50% belong to age between 30-40 years. 
¾ Married and widowed women were included. 
¾ Nulliparous, Uniparous and multiparous were taken into study. 
¾ Other diseases like bleeding disorders were excluded. 
¾ TVS, diagnostic hysteroscopy and D&C were done in 
premenstrual phase. 
¾ There was excellent correlation of endometrial thickness with 
that of HPE of endometrium.  Most patients with 3-5mm 
thickness were of secretory and proliferative pattern. 
¾ There were no complications encountered during the above 
said procedures. 
¾ Blood group of B was an incidental finding and there is no 
literature to support a particular group in AUB. 
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¾ Most of the endometrial hyperplasia, myomas and polyps were 
diagnosed by diagnostic hysteroscopy when compared to TVS 
or D&C. 
¾ Diagnostic hysteroscopy can be done in an office setting as a 
day care procedure and is considered as a safe procedures with 
minimal complications. 
¾ Women with menorrhagia under 40 may require hysteroscopic 
investigation if intra uterine pathology is suspected following 
transvaginal ultrasound scan or due to severity and persistence 
of symptoms despite recommended medical treatment 
(RCOG) 
¾ Hysteroscopy combined with histological examination is 
considered as “Gold standard” for evaluating a case with 
abnormal uterine bleeding. (Widrich et al, Bakour). 
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CONCLUSION 
 
 Abnormal uterine bleeding (AUB) is one of the most 
commonly encountered condition in OPD.  The most probable cause 
of abnormal uterine bleeding depends on the patients reproductive 
age and the likelihood of endometrial pathology. 
 
 Achary V, Mehte S and Rander A is March 2003, studied 100 
patients and concluded that for detecting submucous myomas and 
endometrial polyp, hysteroscopy has 100 percent sensitivity, 
specificity and very high positive and negative predictive values.  
They concluded that in the diagnosis and management of AUB 
cases, the non invasive TVS should be of first choice. But 
hysteroscopy followed by curettage and histopathology will improve 
the accuracy of clinical diagnosis. 
 
 Organic pathologies which cause abnormal uterine bleeding 
such as endometrial polyp, myoma and endometrial hyperplasia – 
that are commonly not identified by blind dilatation and curettage 
are diagnosed readily by hysteroscopy. 
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 Since the incidence of focal lesions in patient with AUB is 
high, it seems that most beneficial approach is to proceed with 
hysteroscopy complemented by endometrial biopsy early in the 
assessment of AUB.  So, hysteroscopy with endometrial biopsy is 
the gold standard investigation for AUB. 
 
 Before hysteroscopy was available, curettage was the primary 
method of evaluating abnormal uterine bleeding.  Brooks and Serden 
have revealed that approximately half of pedunculated abnormalities 
such as endometrial polyp  were missed by curettage.  It renders 
endometrial sampling blind and incomplete, so that the diagnostic 
accuracy of curettage is less than that of hysteroscopy followed by 
curettage biopsy.  So, hysteroscopy combined with histological 
examination is considered better than TVS and D&C. 
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PROFORMA 
 
Name               OP/ IP No.   Unit 
Age     Income  Date of Adm. 
Address       Date of Dis. 
        Date of Operation : 
Socio economic Status of the Patient: 
Parity     : 
Use of oral Contraception  : 
Complaints with Duration  : 
• Previous Medical/ Surgical History   : 
• Family History  : 
• Gynaec. History  : 
• Menarche   : 
• Period :  Cycle Length:   Duration of flow: 
• Amount of flow: Moderate:    Profuse:  Scanty: 
• Pain with Menstruation  : 
• Other symptoms  : 
• Intermenstrual spotting : 
• Marital History    Married   Widow 
• Obstetric History  :  Type of Deliveries  LCB 
• Contraception  :   Temporary  
 Permanent 
• General Examinations : 
Obesity :   Anaemia : 
Breast  :   Thyroid : 
• Systemic Examination   : 1. PR  2. BP   3. CVS 
                 4. RS  5. Abdomen  6. CNS 
• Gynaecological Examination:  P/A : 
P/V :      S/E  : 
P/R  : 
• Investigation :   Ht: Wt:  Hb%  Blood Grouping: 
Urine:  Albumin  Sugar    BT:  CT: 
USG 
Hystroscope Findings: 
Follow up 
1.  D & C     2. HPE 
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ABBREVIATIONS 
AUB ABNORMAL UTERINE BLEEDING 
TVS TRANSVAGINAL SONOGRAPHY 
D&C DILATATION AND CURETTAGE 
HPE HISTOPATHOLOGICAL EXAMINATION 
USG ULTRASONOGRAPHY 
CGH CYSTOGLANDULAR HYPERPLASIA 
EH ENDOMETRIAL HYPERPLASIA 
EP ENDOMETRIAL POLYP 
SM SUBMUCOUS MYOMA  
T TREATED 
NT NOT TREATED 
R REGULAR 
IR IRREGULAR 
N NORMAL STUDY 
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HYSTEROSCOPY 
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ENDOMETRIAL POLYP 
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SUBMUCOUS MYOMA 
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ENDOMETRIAL HYPERPLASIA 
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ENDOMETRIAL HYPERPLASIA 
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RIGHT TUBAL OSTIA 
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1 Janaki 415197 47 3 V 60 T IR  -  + B +ve 9 EH EH CGH Cervicitis EH EH
2 Backiam 155726 42 3 V 73 NT R  +  - A +ve 3 N N Proliferation Inflammatory N N
3 Chandra 470248 30 1 IV 42 NT R  -  - B +ve 3 N N Secretory N N N
4 Maryma 470235 32 2 IV 40 NT R  +  + B +ve 3 S. Myoma S. Myoma Proliferation Cervicitis SM SM
5 Vasantha 490395 31 1 V 45 NT IR  +  - O +ve 2 N N Secretory N N N
6 Murugeswari 41515 30 2 IV 67 NT R  -  + O +ve 3 End.polyp EP+SM Proliferation&polyp N EP EP&SM
7 Tamilselvi 70971 48 3 IV 72 T IR  +  - B +ve 6 N EP Proliferation Inflammatory N EP
8 Selvi 70989 32 0 IV 32 T R  +  + B +ve 6 N EP Proliferation&polyp N N EP
9 Murugeswari 18349 33 1 V 60 NT IR  -  + B +ve 2 N N Secretory N N N
10 Saraswathy 36410 40 4 V 70 NT R  +  + O +ve 7 N EH Proliferation Inflammatory N EH
11 Guruvammal 41360 43 3 IV 48 NT R  +  + B +ve 6 N EH Proliferation Inflammatory N EH
12 Pandiammal 41347 48 1 V 52 T IR  -  + B +ve 8 EH EH Proliferation Cervicitis EH EH
13 Alagu 76171 40 4 V 48 NT R  -  + B +ve 2 N N Secretory N N N
14 Petchiammal 700613 40 3 V 62 NT R  -  + O +ve 3 N EP Proliferation&polyp Inflammatory N EP
15 Arumugam 41632 45 6 V 78 T IR  +  - B +ve 7 Myoma SM Proliferation Inflammatory SM SM
16 Kalaiyarasi 41615 40 2 V 55 NT R  +  + B +ve 3 EH EH Secretory N EH EH
17 Meenammal 40105 35 1 IV 60 T R  +  - B +ve 6 N EP Proliferation N N EP
18 Gomathi 10564 43 1 IV 52 NT IR  +  + A +ve 6 End.polyp EP Proliferation N EP EP
19 Saraswathy 37217 29 4 IV 48 NT IR  -  - B +ve 2 N N Secretory Cervicitis N N
20 Maheswari 41627 28 2 IV 75 T R  -  + O +ve 2 N N Secretory Inflammatory N N
21 Shanthi 41946 35 1 V 62 NT R  +  + B +ve 3 N N Adenomatous Inflammatory N N
22 Vasantha 42041 28 3 IV 72 NT IR  +  - B +ve 2 N EP Proliferative Inflammatory N N
23 Jeyakodi 42044 37 4 V 55 NT R  -  + B +ve 3 EH EH CGH Inflammatory EH EH
MASTER CHART
24 Valli 19731 47 1 V 40 NT IR  +  - B +ve 2 N N Secretory Inflammatory N N
25 Maruthi 105697 45 1 III 42 NT IR  +  + B +ve 2 N N Secretory Inflammatory N N
26 Karuthaveena 107538 45 3 V 55 NT R  +  - B +ve > 1cm EH EH CGH Inflammatory EH EH
27 Deepa 107555 28 5 III 80 T IR  -  - A +ve 3 N N endometritis Cervicitis N N
28 Shanthi 10078 35 1 IV 70 NT R  +  + B +ve 3 N N Secretory Inflammatory N N
29 Ponnu 79518 38 5 V 45 NT R  +  + O +ve 3 EH EH CGH N EH EH
30 Nageswari 79507 27 1 V 50 T IR  -  + B +ve 3 N EH CGH Cervicitis N EH
31 Pappathy 11102 44 1 IV 52 T R  +  - B +ve 2 N Secretory N N N
32 Muthumari 97019 41 3 V 40 NT R  +  - A +ve 9 EH EH CGH Inflammatory EH EH
33 Selvi 12782 33 0 V 72 NT R  -  + B +ve 3 EH EH CGH Inflammatory EH EH
34 Rajalakshmi 13989 30 2 IV 75 NT IR  -  - B +ve 3 EH EP Proliferative+polyp N EH EP
35 Taj Nisha 18385 37 4 V 71 T R  -  + B +ve 3 EP EP Proliferative+polyp Inflammatory EP EP
36 Kokila 45608 45 3 IV 88 NT R  +  - O +ve 2 N N Secretory Inflammatory N N
37 Savithiri 98072 53 0 III 90 T IR  -  - B +ve 2 N N Secretory Dysplasia N N
38 Gnanam 95058 26 1 V 48 T R  +  + AB +ve 3 N EP Proliferative Cervicitis N EP
39 Latha 90312 32 3 V 45 NT R  +  + B +ve 3 N EH Secretory Inflammatory N EH
40 Andichi 53757 30 4 V 47 NT R  +  + B +ve 2 N EP Proliferative+polyp Inflammatory N EP
41 Rajathi 91641 28 2 IV 55 NT IR  -  + A +ve 3 EP EP Proliferative N E Polyp EP
42 Chinnakaruppu 913217 40 2 V 48 NT IR  +  + B +ve 2 N EH Proliferative Inflammatory N EH
43 Kaliammal 42021 38 3 V 60 NT R  +  + O +ve 2 N N Secretory N N N
44 Ponnuthai 73676 25 1 V 68 T R  +  + A +ve 2 N N Secretory Inflammatory N N
45 Ponnu 79518 38 4 V 72 NT R  -  + B +ve 2 N EH CGH Inflammatory N EH
46 Nageswari 79509 27 0 IV 46 NT R  +  + B +ve 3 N N Secretory Inflammatory N N
47 Jeya 79799 40 2 V 88 NT IR  +  + AB +ve 3 N EH Proliferative Inflammatory N EH
48 Panchavarnam 85130 35 3 V 42 NT R  +  + B +ve 3 EP EP Proliferative Inflammatory EP EP
49 Eswari 85136 37 5 V 58 T R  +  + B +ve 2 N N Secretory Inflammatory N N
50 Rathi 43133 43 6 V 63 NT IR  +  - B +ve 2 N N Secretory Inflammatory N N
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